Apyx Medical Corp (APYX) SEC filings

APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/3035% above fair value

$3.00+0.07 (+2.39%)

Close on Nov 11, 2026Market cap $126.37MP/E –Yield –

SEC filings

40 of Apyx Medical's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Sep 30, 2026	Nov 5, 2026	SEC EDGAR
Current report	8-K	Nov 5, 2026	Nov 5, 2026	SEC EDGAR
Current report	8-K	Sep 29, 2026	Sep 29, 2026	SEC EDGAR
Current report	8-K	Aug 6, 2026	Aug 7, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 6, 2026	SEC EDGAR
Current report	8-K	Aug 6, 2026	Aug 6, 2026	SEC EDGAR
Current report	8-K	Jul 24, 2026	Jul 24, 2026	SEC EDGAR
Proxy statement	DEF 14A	Dec 31, 2025	Jun 26, 2026	SEC EDGAR
Current report	8-K	Jun 11, 2026	Jun 17, 2026	SEC EDGAR
Current report	8-K	May 21, 2026	May 21, 2026	SEC EDGAR
Current report	8-K	May 14, 2026	May 14, 2026	SEC EDGAR
Current report	8-K	May 11, 2026	May 11, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 7, 2026	SEC EDGAR
Current report	8-K	May 7, 2026	May 7, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Mar 10, 2026	SEC EDGAR
Current report	8-K	Mar 10, 2026	Mar 10, 2026	SEC EDGAR
Current report	8-K	Jan 12, 2026	Jan 12, 2026	SEC EDGAR
Current report	8-K	Dec 8, 2025	Dec 12, 2025	SEC EDGAR
Current report	8-K	Nov 17, 2025	Nov 19, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 6, 2025	SEC EDGAR
Current report	8-K	Nov 6, 2025	Nov 6, 2025	SEC EDGAR
Current report	8-K	Aug 7, 2025	Aug 13, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 7, 2025	SEC EDGAR
Current report	8-K	Aug 7, 2025	Aug 7, 2025	SEC EDGAR
Proxy statement	DEF 14A	Dec 31, 2024	Jun 25, 2025	SEC EDGAR
Current report	8-K	May 13, 2025	May 13, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 8, 2025	SEC EDGAR
Current report	8-K	May 8, 2025	May 8, 2025	SEC EDGAR
Current report	8-K	Apr 29, 2025	Apr 29, 2025	SEC EDGAR
Annual report	10-K	Dec 31, 2024	Mar 13, 2025	SEC EDGAR
Current report	8-K	Mar 13, 2025	Mar 13, 2025	SEC EDGAR
Current report	8-K	Jan 31, 2025	Feb 6, 2025	SEC EDGAR
Current report	8-K	Jan 13, 2025	Jan 13, 2025	SEC EDGAR
Current report	8-K	Jan 6, 2025	Jan 6, 2025	SEC EDGAR
Current report	8-K	Nov 4, 2024	Nov 8, 2024	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2024	Nov 8, 2024	SEC EDGAR
Current report	8-K	Aug 8, 2024	Aug 12, 2024	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2024	Aug 8, 2024	SEC EDGAR
Current report	8-K	Aug 8, 2024	Aug 8, 2024	SEC EDGAR
Proxy statement	DEF 14A	Dec 31, 2023	Jun 25, 2024	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Apyx Medical's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is APYX.

Compare: APYX vs RCEL · APYX vs TELA · APYX vs LNSR · APYX vs MHUAF · APYX vs PDEX

Revenue growth24.4% · median 7.4%

Gross margin63.4% · median 59.6%

Operating margin-5.5% · median -18.6%

Net margin-14.2% · median -13.8%

Company	Revenue	Growth
RCEL	$84.68M	+17.0%
PDEX	$79.58M	+13.3%
TELA	$78.18M	+1.5%
LNSR	$60.08M	+1.6%
APYX	$59.57M	+24.4%
MHUAF	–	–

Company

Next earnings (est.): Mar 9, 2027, before open
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 205
Held by institutions: 58.5%
Auditor: RSM US LLP
SEC CIK: 719135

Advertisement
300 × 250

See a number that looks wrong?